Startups
Edit
https://www.us.sumitomo-pharma.com/
Sumitomo Pharma America, Inc.
TrustedLast activity: 12.03.2026
Active
Sumitomo Pharma America, Inc. advances innovative treatments across oncology, women's health, urology, rare disease and CNS to help improve patients' lives.
Overview
Location
United States, Massachusetts, Cambridge
Employees
5001-10000
Founded date
2005
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 8, 2025 | Asia-Pacific markets trade mixed after Trump rules out tariff deadline extension | This is CNBC’s live blog covering Asia-Pacific markets. Asia-Pacific markets traded mixed Wednesday after U.S. President Donald Trump ruled out a deadline extension on tariffs set to kick off on Aug. 1. Trump on Tuesday stateside also annou... |
| Jun 27, 2025 | Asia-Pacific Markets Navigate Mixed Signals Amid Economic Data and Corporate Moves | The Asia-Pacific markets are like a ship caught in a storm, swaying between optimism and caution. Investors are grappling with mixed signals, particularly from China’s industrial data, which has cast a shadow over the region. The National B... |
| Jun 26, 2025 | Asia-Pacific markets mostly lower as investors assess China industrial data | This is CNBC’s live blog covering Asia-Pacific markets. Asia-Pacific markets traded mixed Friday as investors assessed China’s May industrial data. The country’s industrial profits fell 9.1% year on year in the first five months of the year... |
| Aug 22, 2024 | Dollar down and oil slips as Fed readies rate cuts | MarketsDollar down and oil slips as Fed readies rate cuts By Tom WestbrookAugust 22, 20246:08 AM UTCUpdated ago Text Small Text Medium Text Large Text Share X Facebook Linkedin Email Link Item 1 of 2 The Federal Reserve Building stands in W... |
| Apr 2, 2024 | Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million | |
| Dec 19, 2023 | AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time | The numbers in drug discovery are daunting. Identifying a molecule with therapeutic promise and advancing it through preclinical and clinical development can take more than a decade at costs topping $2 billion, according to pharmaceutical i... |
| Oct 24, 2023 | Time Is Running Out to Register for MedCity INVEST Digital Health in Dallas on October 26 | The INVEST Digital Health conference, a collaboration between MedCity News and the Health Wildcatters accelerator, is coming up this Thursday, October 26. Held at Pegasus Park in Dallas, the conference spotlights a wide range of hot topics ... |
| Jul 31, 2023 | Sumitomo Schizophrenia Drug Discovered With AI Tech Fails in Two Phase 3 Trials | Schizophrenia drugs mainly go after the same target in the brain, but drug developers are hoping to improve on the efficacy and side effect profile of such medicines by going after new targets. The prospects for one such therapy from Sumito... |
| Dec 11, 2022 | Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients with Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition | CAMBRIDGE, Mass., Dec. 10, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today presented new data from the ongoing Phase 1/2 study evaluating TP-3654, an investigational ... |
Reviews 0
FAQ about Sumitomo Pharma America, Inc.
When was Sumitomo Pharma America, Inc. founded?
Sumitomo Pharma America, Inc. was founded in 2005.
What has the press written about Sumitomo Pharma America, Inc.?
Parsers VC has collected 10 articles mentioning Sumitomo Pharma America, Inc., among them “Asia-Pacific markets trade mixed after Trump rules out tariff deadline extension” (Jul 8, 2025) and “Asia-Pacific Markets Navigate Mixed Signals Amid Economic Data and Corporate Moves” (Jun 27, 2025).
Is Sumitomo Pharma America, Inc. still active?
Yes, Sumitomo Pharma America, Inc. is active; its latest activity on Parsers VC dates from Mar 12, 2026.